<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule Toprule">Interacting Drug </th>
<th align="center" stylecode="Lrule Rrule Toprule">Interaction </th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">   Multivalent cation-containing products<br/>   including antacids, metal cations or didanosine    <br/>
</td>
<td stylecode="Rrule" valign="top">   Do not co-administer the intravenous formulation in the same IV line with a multivalent cation, e.g., magnesium <linkhtml href="#Section_2.4">(2.4</linkhtml>, <linkhtml href="#Section_7.1">7.1)</linkhtml>   <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">   Warfarin <br/>
</td>
<td stylecode="Rrule" valign="top">   Effect may be enhanced. Monitor prothrombin time, INR, watch for bleeding <linkhtml href="#Section_7.2">(7.2)</linkhtml>
<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">   Antidiabetic agents <br/>
</td>
<td stylecode="Rrule" valign="top">   Carefully monitor blood glucose (<linkhtml href="#Section_5.11">5.12</linkhtml>, <linkhtml href="#Section_7.3">7.3)</linkhtml>
<br/>
</td>
</tr>
</tbody>
</table>